{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:06:45Z","timestamp":1761523605043},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s10120-008-0484-5","type":"journal-article","created":{"date-parts":[[2009,1,7]],"date-time":"2009-01-07T01:03:21Z","timestamp":1231290201000},"page":"201-205","source":"Crossref","is-referenced-by-count":19,"title":["Combination chemotherapy with cisplatin and irinotecan in patients with adenocarcinoma of the small intestine"],"prefix":"10.1007","volume":"11","author":[{"given":"Makiko","family":"Ono","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuniaki","family":"Shirao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuo","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chigusa","family":"Morizane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsuko","family":"Okita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Takahari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Hirashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takako","family":"Eguchi-Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhide","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,1,8]]},"reference":[{"key":"484_CR1","first-page":"116","volume":"15","author":"S.W. Ashley","year":"1988","unstructured":"Ashley SW, Wells SA Jr. Tumors of the small intestine. Semin Oncol 1988;15:116\u2013128.","journal-title":"Semin Oncol"},{"key":"484_CR2","first-page":"529","volume":"21","author":"A.I. Neugut","year":"1997","unstructured":"Neugut AI, Marvin MR, Rella VA, Chabot JA. An overview of adenocarcinoma of the small intestine. Oncology 1997;21:529\u2013536.","journal-title":"Oncology"},{"key":"484_CR3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3816\/CCC.2004.n.023","volume":"4","author":"T. Delaunoit","year":"2004","unstructured":"Delaunoit T, Neczyporenko F, Limburg PJ, Erlichman C. Small bowel adenocarcinoma: a rare but aggressive disease. Clin Colorectal Cancer 2004;4:241\u2013248.","journal-title":"Clin Colorectal Cancer"},{"key":"484_CR4","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0889-8553(02)00010-9","volume":"31","author":"P.H. Green","year":"2002","unstructured":"Green PH, Jabri B. Celiac disease and other precursors to smallbowel malignancy. Gastroenterol Clin North Am 2002;31:625\u2013639.","journal-title":"Gastroenterol Clin North Am"},{"key":"484_CR5","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1634\/theoncologist.10-2-132","volume":"10","author":"M.K. Gibson","year":"2005","unstructured":"Gibson MK, Holcroft CA, Kvols LK, Haller D. Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma. Oncologist 2005;10:132\u2013137.","journal-title":"Oncologist"},{"key":"484_CR6","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000089678","volume":"69","author":"C. Locher","year":"2005","unstructured":"Locher C, Malka D, Boige V, Lebray P, Elias D, Lasser P, et al. Combination chemotherapy in advanced small bowel adenocarcinoma. Oncology 2005;69:290\u2013294.","journal-title":"Oncology"},{"key":"484_CR7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1179\/joc.2003.15.6.607","volume":"15","author":"A. Polyzos","year":"2003","unstructured":"Polyzos A, Kouraklis G, Giannopoulos A, Bramis J, Delladetsima JK, Sfikakis PP. Irinotecan as salvage chemotherapy for advanced small bowel adenocarcinoma: a series of three patients. J Chemother 2003;15:503\u2013506.","journal-title":"J Chemother"},{"key":"484_CR8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/1097-0142(19840101)53:1<23::AID-CNCR2820530106>3.0.CO;2-U","volume":"53","author":"D. Jigyasu","year":"1984","unstructured":"Jigyasu D, Bedikian AY, Stroehlein JR. Chemotherapy for primary adenocarcinoma of the small bowel. Cancer 1984;53:23\u201325.","journal-title":"Cancer"},{"key":"484_CR9","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/bjc.1998.523","volume":"78","author":"C. Crawley","year":"1998","unstructured":"Crawley C, Ross P, Norman A, Hill A, Cunningham D. The Royal Marsden experience of small bowel adenocarcinoma treated with protracted venous infusion 5-fluorouracil. Br J Cancer 1998;78:508\u2013510.","journal-title":"Br J Cancer"},{"key":"484_CR10","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1200\/JCO.1997.15.3.921","volume":"15","author":"K. Shirao","year":"1997","unstructured":"Shirao K, Shimada Y, Kondo H, Saito D, Yamao T, Ono H, et al. Phase I-II study of irinotecan hydrochloride combined with cisplatin in patients with advanced gastric cancer. J Clin Oncol 1997;15:921\u2013927.","journal-title":"J Clin Oncol"},{"key":"484_CR11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1200\/JCO.1999.17.1.319","volume":"17","author":"N. Boku","year":"1999","unstructured":"Boku N, Ohtsu A, Shimada Y, Shirao K, Seki S, Saito H, et al. Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer. J Clin Oncol 1999;17:319\u2013323.","journal-title":"J Clin Oncol"},{"issue":"18S","key":"484_CR12","doi-asserted-by":"crossref","first-page":"LBA4513","DOI":"10.1200\/jco.2007.25.18_suppl.lba4513","volume":"25","author":"N. Boku","year":"2007","unstructured":"Boku N, Yamamoto S, Shirao K, Doi T, Sawaki A, Koizumi H, et al. Randomized phase III study of 5-fluorouracil (5-FU) alone versus combination of irinotecan and cisplatin (CP) versus S-1 alone in advanced gastric cancer (JCOG9912). J Clin Oncol 2007;25(18S):LBA4513.","journal-title":"J Clin Oncol"},{"key":"484_CR13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/01. coc.0000214931.01062.01","volume":"29","author":"P.N. Fishman","year":"2006","unstructured":"Fishman PN, Pond GR, Moore MJ, Oza A, Burkes RL, Siu LL, et al. Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: a retrospective review of 113 cases. Am J Clin Oncol 2006;29:225\u2013231.","journal-title":"Am J Clin Oncol"},{"key":"484_CR14","first-page":"107a","volume":"21","author":"C. Erlichman","year":"2002","unstructured":"Erlichman C, Goldberg RM, Sloan JA, Reid JM, Adjei AA, Atherton PJ, et al. Phase I study of the combination of CPT-11\/5FU\/leucovorin\/oxaliplatin. Proc Am Soc Clin Oncol 2002;21:107a (Abstract No. 426).","journal-title":"Proc Am Soc Clin Oncol"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-008-0484-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10120-008-0484-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-008-0484-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T12:05:25Z","timestamp":1589457925000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10120-008-0484-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["484"],"URL":"https:\/\/doi.org\/10.1007\/s10120-008-0484-5","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}